Welcome to DRGT

Druggability Technologies (DRGT) is a proprietary pharmaceutical product business dedicated to the development and commercialization of high-value pharmaceutical products that deliver measurable and meaningful improvement in clinical efficacy. This mission is enabled through the deployment of the Company's Super-API technology that delivers substantial improvement in pharmacokinetics/pharmacodynamics/bioavailability resulting in high-value, proprietary products.

The Super-API technology delivers highly significant improvement in solubility, permeability and kinetics with unique properties unattainable by traditional approaches and provides a basis for creating composition of matter like IP.

DRGT not only applies its technology to compounds in development by BioPharma partners, but also to in-marketed drugs near or at the end of their proprietary life cycle creating an internal pipeline of drugs with improved clinical performance in oncology and various other therapeutic area.